Table 5.
Adverse events observed in the immediate post transplantation period
| Adverse Events | Present during the period of follow up | Absent during the period of follow up | ||
|---|---|---|---|---|
|
| ||||
| Procedure related | Cellular transplantation related | Procedure related | Cellular transplantation related | |
| Minor | • Spinal Headache (30.43%) | None | • Bleeding at the site of injection | None |
| • Nausea (4.34%) | • Bleeding at the site of aspiration | |||
| • Vomiting (4.34%) | ||||
| • Pain at the site of injection (4.34%) | ||||
| • Pain at the site of aspiration (8.67%) | ||||
| • Fatigue (4.34 %) | ||||
| Major | None | • Neurological deficits | • Allergic reaction | |
| • Nerve root damage | ||||
| • Parasthesia in Lower Limb | ||||
| • Loss of sensation in lower limb | ||||
| • Loss of motor function in the lower limbs | ||||
| • Hematoma at the site of injection | ||||
| • Hematoma at the site of aspiration | ||||
| • Local infection at the site of injection or aspiration | ||||
| • Meningismus or meningitis | ||||
| • Systemic or brain infection | ||||
| • Bowel or bladder incontinence | ||||
| • Respiratory distress | ||||
| • Cardiac failure | ||||
| • Sudden onset of respiratory discomfort | ||||
| • Breathlessness | ||||